Mara Lorenzi

Romeo G, Liu W-H, Asnaghi V, Kern TS, Lorenzi M. Activation of nuclear factor-kB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 2002; 51:2241-2248.

Zhang J, Gerhardinger C, Lorenzi M. Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy. Diabetes 2002; 51:3499-3504.

Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 2003; 52: 506-511.

Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M:   Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy.   Diabetes 2004, 53:2404-2411.

Sun W, Gerhardinger C, Dagher Z, Hoehn T, Lorenzi M: Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects. Diabetes 2005; 54:3418-3426.

Sun W, Oates PJ, Coutcher JB, Gerhardinger C, Lorenzi M: A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Diabetes 2006; 55:2757-2762.

Lorenzi M. Mechanisms and strategies for prevention in diabetic retinopathy. Current Diabetes Reports 2006; 6:102-107.

Lorenzi M, Feke GT, Cagliero E, Pitler L, Schaumberg DA, Berisha F, Nathan DM, McMeel JW: Retinal haemodynamics in individuals with well-controlled type 1 diabetes.  Diabetologia 2007 In press. DOI 10.1007/s00125-007-0872-0.

Lorenzi, M. The polyol pathway as a mechanism for diabetic retinopathy: Attractive, elusive,  and resilient. Experimental Diabetes Research 2007; vol 2007, Article ID 61038, doi:10.1155/2007/61038.